AI generated summary of Pubmed citation/abstract with PMID 38093277

https://pubmed.ncbi.nlm.nih.gov/38093277

Patients with biopsy-confirmed metabolic dysfunction-associated steatotic liver disease (MASLD) have a higher incidence of cardiac arrhythmias, including atrial fibrillation, bradyarrhythmias, other supraventricular arrhythmias, and ventricular arrhythmias/cardiac arrest, compared to matched controls, with the highest risk observed in cirrhosis.